Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration

Both programmes demonstrate Exscientia's ability to design highly differentiated, potentially best-in-class molecules Exscientia will receive $15 million for achieving these milestones and is eligible for over $600